Krishna Institute of Medical Sciences Ltd, 543308, KIMS Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

16,765.02
54.06
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

17,762.25
N/A
9.17

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

20.13
-
18.23

EBITDA CAGR (%)

10 Years
5 Years
3 Years

25.08
-
9.78

PAT CAGR (%)

10 Years
5 Years
3 Years

54.46
-
18.68

P:E (Median)

8 Years
5 Years
3 Years

-
-
45.45

P:BV (Average)

8 Years
5 Years
3 Years

-
-
7.84

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
-
23.63

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 24 Mar 23 Var% Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var%
Net Sales 304.85 293.35 3.92% 302.06 283.51 6.54% 316.25 292.21 8.23% 298.90 262.95 13.67%
Expenses 218.56 189.03 15.62% 214.58 193.54 10.87% 217.95 204.35 6.66% 206.56 184.82 11.76%
EBITDA 86.29 104.33 -17.29% 87.48 89.97 -2.77% 98.29 87.86 11.87% 92.34 78.13 18.19%
EBIDTM 28.31% 35.56% 28.96% 31.73% 31.08% 30.07% 30.89% 29.71%
Other Income 3.90 3.89 0.26% 4.23 7.18 -41.09% 3.57 7.63 -53.21% 3.84 3.71 3.50%
Interest 2.31 0.18 1,183.33% 1.22 0.24 408.33% 0.05 0.33 -84.85% 0.08 0.41 -80.49%
Depreciation 20.41 11.16 82.89% 12.78 11.35 12.60% 12.79 11.38 12.39% 12.12 11.41 6.22%
PBT 67.47 96.88 -30.36% 77.71 85.56 -9.17% 89.02 83.78 6.25% 83.98 70.02 19.94%
Tax 19.27 23.27 -17.19% 19.35 21.10 -8.29% 22.86 22.58 1.24% 21.34 17.90 19.22%
PAT 48.19 73.61 -34.53% 58.35 64.47 -9.49% 66.16 61.20 8.10% 62.63 52.12 20.17%
PATM 15.81% 25.09% 19.32% 22.74% 20.92% 20.95% 20.95% 19.82%
EPS 6.02 9.20 -34.57% 7.29 8.06 -9.55% 8.27 7.65 8.10% 7.83 6.52 20.09%

Description Mar 24 Mar 23 Var% Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var%
Net Sales 633.80 575.93 10.05% 605.84 562.16 7.77% 652.48 564.07 15.67% 606.03 495.51 22.30%
Expenses 474.83 412.69 15.06% 458.71 410.98 11.61% 475.21 411.64 15.44% 448.96 358.35 25.29%
EBITDA 158.97 163.23 -2.61% 147.12 151.18 -2.69% 177.27 152.43 16.30% 157.06 137.16 14.51%
EBIDTM 25.08% 28.34% 24.28% 26.89% 27.17% 27.02% 25.92% 27.68%
Other Income 3.81 4.88 -21.93% 3.25 6.45 -49.61% 2.88 9.20 -68.70% 3.11 5.34 -41.76%
Interest 16.36 5.42 201.85% 12.43 11.52 7.90% 8.91 7.88 13.07% 9.33 5.73 62.83%
Depreciation 46.30 35.43 30.68% 35.38 33.29 6.28% 32.61 31.12 4.79% 32.27 29.42 9.69%
PBT 100.12 127.27 -21.33% 102.57 112.82 -9.09% 138.64 137.47 0.85% 118.58 107.35 10.46%
Tax 28.50 28.60 -0.35% 25.90 30.99 -16.42% 37.32 31.40 18.85% 31.91 28.11 13.52%
PAT 71.62 98.67 -27.41% 76.67 81.83 -6.31% 101.32 106.07 -4.48% 86.67 79.25 9.36%
PATM 11.30% 17.13% 12.66% 14.56% 15.53% 18.80% 14.30% 15.99%
EPS 8.18 11.65 -29.79% 8.98 9.49 -5.37% 11.50 12.13 -5.19% 10.10 8.74 15.56%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Net Sales 1,222.06 1,132.02 1,143.38 932.69 789.97 535.73 484.94 393.96 349.45 293.58 183.35 Net Sales Growth 7.95% -0.99% 22.59% 18.07% 47.46% 10.47% 23.09% 12.74% 19.03% 60.12% Cost Of Goods Sold 250.70 237.56 249.91 201.19 179.85 130.08 118.80 103.90 99.00 86.65 52.88 Gross Profit 971.36 894.46 893.47 731.49 610.12 405.65 366.14 290.05 250.45 206.94 130.48 GP Margin 79.49% 79.01% 78.14% 78.43% 77.23% 75.72% 75.50% 73.62% 71.67% 70.49% 71.16% Total Expenditure 857.65 768.88 745.50 625.11 584.13 421.48 380.38 320.87 284.36 232.56 144.69 Power & Fuel Cost - 17.25 14.49 14.48 14.63 13.40 12.92 11.34 11.89 8.92 4.58 % Of Sales - 1.52% 1.27% 1.55% 1.85% 2.50% 2.66% 2.88% 3.40% 3.04% 2.50% Employee Cost - 187.25 174.02 147.04 136.97 91.15 75.93 65.72 54.65 43.37 23.26 % Of Sales - 16.54% 15.22% 15.77% 17.34% 17.01% 15.66% 16.68% 15.64% 14.77% 12.69% Manufacturing Exp. - 269.51 266.73 228.65 23.99 157.78 141.28 119.32 97.45 79.79 4.63 % Of Sales - 23.81% 23.33% 24.52% 3.04% 29.45% 29.13% 30.29% 27.89% 27.18% 2.53% General & Admin Exp. - 48.21 29.19 22.70 37.29 22.24 23.17 15.10 14.69 11.21 50.04 % Of Sales - 4.26% 2.55% 2.43% 4.72% 4.15% 4.78% 3.83% 4.20% 3.82% 27.29% Selling & Distn. Exp. - 0.00 0.00 0.00 5.55 0.00 0.00 2,054,936.90 0.00 0.00 0.00 % Of Sales - 0% 0% 0% 0.70% 0% 0% 521610.54% 0% 0% 0% Miscellaneous Exp. - 9.10 11.16 11.05 191.41 6.83 8.29 5.48 6.69 2.62 0.00 % Of Sales - 0.80% 0.98% 1.18% 24.23% 1.27% 1.71% 1.39% 1.91% 0.89% 5.08% EBITDA 364.40 363.14 397.88 307.58 205.84 114.25 104.56 73.09 65.09 61.02 38.66 EBITDA Margin 29.82% 32.08% 34.80% 32.98% 26.06% 21.33% 21.56% 18.55% 18.63% 20.78% 21.09% Other Income 15.54 24.28 26.96 9.62 7.09 2.82 4.36 4.06 5.73 2.75 2.85 Interest 3.66 4.80 8.91 18.33 23.76 32.03 36.24 34.05 30.72 15.08 6.22 Depreciation 58.10 45.30 44.92 44.60 42.66 33.77 34.23 30.96 24.72 20.96 10.41 PBT 318.18 337.33 371.00 254.26 146.50 51.27 38.44 12.14 15.39 27.73 24.88 Tax 82.82 84.84 92.64 65.61 25.40 18.73 14.15 6.34 11.19 9.46 8.26 Tax Rate 26.03% 25.15% 24.97% 25.80% 17.34% 36.53% 36.81% 52.22% 72.71% 34.11% 33.20% PAT 235.33 252.49 278.37 188.65 121.11 32.54 24.30 5.80 4.19 18.27 16.62 PAT before Minority Interest 235.33 252.49 278.37 188.65 121.11 32.54 24.30 5.80 4.19 18.27 16.62 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 19.26% 22.30% 24.35% 20.23% 15.33% 6.07% 5.01% 1.47% 1.20% 6.22% 9.06% PAT Growth -6.39% -9.30% 47.56% 55.77% 272.19% 33.91% 318.97% 38.42% -77.07% 9.93% EPS 29.42 31.56 34.80 23.58 15.14 4.07 3.04 0.73 0.52 2.28 2.08

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Net Sales 2,498.15 2,197.68 1,650.83 1,329.94 1,122.64 567.14 511.82 419.68 351.03 293.76 Net Sales Growth 13.67% 33.13% 24.13% 18.47% 97.95% 10.81% 21.95% 19.56% 19.50% Cost Of Goods Sold 530.30 480.65 355.16 288.93 254.17 138.50 125.83 111.89 99.25 86.64 Gross Profit 1,967.85 1,717.03 1,295.67 1,041.01 868.48 428.64 386.00 307.79 251.78 207.11 GP Margin 78.77% 78.13% 78.49% 78.27% 77.36% 75.58% 75.42% 73.34% 71.73% 70.50% Total Expenditure 1,857.71 1,598.48 1,129.19 954.22 873.16 449.51 402.95 342.42 287.10 232.99 Power & Fuel Cost - 43.69 25.83 24.31 24.29 14.18 13.68 12.15 11.99 8.93 % Of Sales - 1.99% 1.56% 1.83% 2.16% 2.50% 2.67% 2.90% 3.42% 3.04% Employee Cost - 346.44 261.91 220.21 198.05 97.97 80.72 69.23 55.65 43.45 % Of Sales - 15.76% 15.87% 16.56% 17.64% 17.27% 15.77% 16.50% 15.85% 14.79% Manufacturing Exp. - 618.94 420.59 366.51 336.25 167.43 149.25 127.52 97.80 79.88 % Of Sales - 28.16% 25.48% 27.56% 29.95% 29.52% 29.16% 30.39% 27.86% 27.19% General & Admin Exp. - 95.74 48.48 38.32 43.64 24.29 24.81 16.13 15.57 11.32 % Of Sales - 4.36% 2.94% 2.88% 3.89% 4.28% 4.85% 3.84% 4.44% 3.85% Selling & Distn. Exp. - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 % Of Sales - 0% 0% 0% 0% 0% 0% 0% 0% 0% Miscellaneous Exp. - 13.03 17.24 15.94 16.76 7.14 8.65 5.50 6.84 2.77 % Of Sales - 0.59% 1.04% 1.20% 1.49% 1.26% 1.69% 1.31% 1.95% 0.94% EBITDA 640.42 599.20 521.64 375.72 249.48 117.63 108.87 77.26 63.93 60.77 EBITDA Margin 25.64% 27.27% 31.60% 28.25% 22.22% 20.74% 21.27% 18.41% 18.21% 20.69% Other Income 13.05 37.41 20.26 10.16 6.08 2.79 4.57 4.19 7.92 2.94 Interest 47.03 37.28 21.87 37.33 44.43 32.50 37.04 35.05 31.20 15.07 Depreciation 146.56 129.26 72.67 69.54 70.61 35.13 35.50 32.27 24.75 20.97 PBT 459.91 470.08 447.34 279.01 140.53 52.78 40.90 14.13 15.90 27.67 Tax 123.63 119.09 113.06 73.54 25.45 19.30 12.93 6.93 11.54 9.46 Tax Rate 26.88% 24.56% 25.27% 26.36% 18.11% 36.57% 31.61% 49.04% 72.58% 34.19% PAT 336.28 336.32 332.69 201.22 119.18 32.93 26.74 6.44 4.35 18.21 PAT before Minority Interest 310.41 365.81 343.80 205.48 115.07 33.48 27.97 7.20 4.36 18.21 Minority Interest -25.87 -29.49 -11.11 -4.26 4.11 -0.55 -1.23 -0.76 -0.01 0.00 PAT Margin 13.46% 15.30% 20.15% 15.13% 10.62% 5.81% 5.22% 1.53% 1.24% 6.20% PAT Growth -8.08% 1.09% 65.34% 68.84% 261.92% 23.15% 315.22% 48.05% -76.11% EPS 42.04 42.04 41.59 25.15 14.90 4.12 3.34 0.81 0.54 2.28

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10 Mar 09
Shareholder's Funds 1,630.86 1,377.55 907.32 624.13 201.77 194.91 160.64 0.00 129.21 52.38 Share Capital 80.03 80.03 77.59 74.49 5.61 3.83 3.83 3.83 3.83 2.90 Total Reserves 1,550.83 1,297.52 829.73 549.64 196.16 189.81 156.82 140.20 125.39 47.48 Non-Current Liabilities 61.53 56.98 116.31 195.36 236.74 188.99 147.81 0.00 56.51 74.99 Secured Loans 0.00 4.17 67.78 147.12 192.13 160.48 112.24 0.00 47.09 44.93 Unsecured Loans 0.00 0.00 0.00 0.00 7.63 0.00 0.00 58.82 0.00 21.74 Long Term Provisions 17.13 15.45 14.25 12.20 2.31 1.46 0.83 0.85 0.00 0.00 Current Liabilities 119.68 134.25 190.09 137.95 188.05 186.93 83.72 0.00 19.11 24.45 Trade Payables 72.73 80.64 85.19 77.98 58.07 39.16 22.76 16.66 16.41 13.56 Other Current Liabilities 39.15 46.82 40.91 52.47 103.17 134.48 58.62 46.64 1.36 1.90 Short Term Borrowings 0.00 0.00 50.00 2.08 26.27 12.54 1.94 0.96 0.00 0.00 Short Term Provisions 7.80 6.79 13.99 5.42 0.54 0.76 0.39 0.26 1.33 8.98 Total Liabilities 1,812.07 1,568.78 1,213.72 957.44 626.56 570.83 392.17 0.00 204.83 151.82 Net Block 612.28 591.97 582.39 559.21 454.56 412.71 200.99 159.77 91.79 90.04 Gross Block 889.12 826.91 775.03 712.13 552.16 490.75 244.08 159.77 116.75 109.07 Accumulated Depreciation 276.84 234.94 192.64 152.92 97.60 78.04 43.09 0.00 24.96 19.04 Non Current Assets 1,575.02 1,237.50 846.50 788.21 532.02 502.46 351.42 0.00 151.76 122.39 Capital Work in Progress 15.97 13.19 7.60 2.23 50.94 73.83 124.35 0.00 59.77 32.15 Non Current Investment 784.87 542.01 213.22 177.96 5.89 1.71 1.70 0.20 0.20 0.20 Long Term Loans & Adv. 158.74 88.17 38.94 48.66 16.76 8.36 19.07 19.90 0.00 0.00 Other Non Current Assets 3.17 2.16 4.35 0.14 3.87 5.85 5.31 1.18 0.00 0.00 Current Assets 237.04 331.28 367.23 169.24 94.54 68.38 40.76 0.00 53.07 29.35 Current Investments 41.17 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 19.24 25.99 16.47 21.71 9.87 8.21 5.42 4.73 4.12 4.16 Sundry Debtors 119.94 87.38 73.00 99.15 32.31 29.51 20.26 19.23 19.15 14.07 Cash & Bank 40.11 179.76 250.02 39.48 25.28 11.40 9.95 14.20 25.61 1.50 Other Current Assets 16.57 5.26 13.41 5.09 27.08 19.25 5.12 3.89 4.19 9.62 Short Term Loans & Adv. 15.08 32.90 14.32 3.81 19.71 14.69 2.70 2.86 3.54 9.40 Net Current Assets 117.36 197.03 177.14 31.29 -93.51 -118.55 -42.96 0.00 33.97 4.91 Total Assets 1,812.06 1,568.78 1,213.73 957.45 626.56 570.84 392.18 0.00 204.83 151.81

Description Mar 23 Mar 22 Mar 21 Mar 20
Shareholder's Funds 1,669.54 1,387.31 863.73 598.13 Share Capital 80.03 80.03 77.59 74.49 Total Reserves 1,589.51 1,307.28 786.14 523.33 Non-Current Liabilities 666.67 278.49 278.70 364.23 Secured Loans 492.54 137.66 184.60 268.72 Unsecured Loans 4.90 0.00 0.00 0.00 Long Term Provisions 23.63 17.05 16.06 13.71 Current Liabilities 296.47 215.00 278.32 218.81 Trade Payables 174.25 129.53 131.87 123.43 Other Current Liabilities 88.60 73.20 72.00 77.92 Short Term Borrowings 19.55 1.76 55.27 10.11 Short Term Provisions 14.06 10.51 19.19 7.35 Total Liabilities 2,901.10 1,904.13 1,433.21 1,194.48 Net Block 1,766.32 1,005.21 931.08 915.98 Gross Block 2,223.45 1,329.42 1,190.02 1,106.30 Accumulated Depreciation 457.13 324.21 258.94 190.33 Non Current Assets 2,423.47 1,510.74 982.02 974.64 Capital Work in Progress 476.93 20.76 9.24 2.23 Non Current Investment 0.00 332.48 0.00 0.00 Long Term Loans & Adv. 171.88 148.73 34.79 55.02 Other Non Current Assets 8.33 3.56 6.91 1.42 Current Assets 477.64 393.40 451.19 219.83 Current Investments 67.89 0.00 0.00 0.00 Inventories 42.87 36.43 24.09 30.38 Sundry Debtors 252.65 128.64 109.82 132.27 Cash & Bank 66.37 190.06 284.44 45.73 Other Current Assets 47.86 5.02 12.88 1.36 Short Term Loans & Adv. 42.83 33.24 19.97 10.10 Net Current Assets 181.17 178.39 172.87 1.02 Total Assets 2,901.11 1,904.14 1,433.21 1,194.47

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 14 Mar 13 Mar 12 Mar 10 Mar 09
Cash From Operating Activity 269.96 284.37 291.35 160.59 79.81 33.16 39.50 18.88 18.84 PBT 337.33 371.00 254.26 146.50 14.17 27.80 24.88 22.67 14.79 Adjustment 24.32 26.50 54.74 62.08 56.11 34.80 10.20 9.98 7.82 Changes in Working Capital -17.17 -16.85 25.07 -0.99 20.89 -21.24 5.86 -5.80 -3.77 Cash after chg. in Working capital 344.48 380.65 334.07 207.59 91.17 41.36 40.94 26.85 18.84 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 5.25 0.00 0.00 Tax Paid -74.52 -96.28 -42.72 -47.01 -11.36 -8.20 -6.69 -7.96 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -236.58 -375.08 -316.60 -108.03 -67.80 -81.48 -104.74 -27.37 -54.60 Net Fixed Assets -64.99 -57.47 -68.27 -111.26 -38.52 -196.15 -191.91 -35.30 Net Investments -284.03 -328.79 -35.26 -172.07 -4.18 -0.01 -1.50 0.00 Others 112.44 11.18 -213.07 175.30 -25.10 114.68 88.67 7.93 Cash from Financing Activity -15.14 75.98 25.37 -24.35 -9.55 48.19 58.56 32.60 35.36 Net Cash Inflow / Outflow 18.24 -14.73 0.12 28.21 2.46 -0.14 -6.67 24.12 -0.40 Opening Cash & Equivalents 19.86 34.59 34.47 6.26 6.62 6.76 12.71 1.50 1.54 Closing Cash & Equivalent 38.10 19.86 34.59 34.47 9.08 6.62 6.04 25.61 1.14

Description Mar 23 Mar 22 Mar 21 Mar 20
Cash From Operating Activity 432.09 324.02 355.97 201.50 PBT 484.91 456.85 279.01 140.53 Adjustment 111.88 68.54 100.56 114.53 Changes in Working Capital -69.28 -74.47 14.15 0.12 Cash after chg. in Working capital 527.50 450.92 393.72 255.17 Interest Paid 0.00 0.00 0.00 0.00 Tax Paid -95.41 -126.90 -37.74 -53.67 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 Cash From Investing Activity -615.60 -411.52 -354.18 -124.71 Net Fixed Assets -64.99 -57.47 -68.27 Net Investments -284.03 -328.79 -35.26 Others -266.58 -25.26 -250.65 Cash from Financing Activity 88.34 61.00 9.82 -44.34 Net Cash Inflow / Outflow -95.17 -26.50 11.62 32.45 Opening Cash & Equivalents 25.63 52.13 40.51 8.06 Closing Cash & Equivalent 61.61 25.63 52.13 40.51

Financial Ratios

Consolidated /

Standalone

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10 Mar 09
Book Value (Rs.) 203.79 172.13 116.93 83.79 359.60 506.17 419.93 376.49 337.76 173.24 ROA 14.94% 20.01% 17.38% 13.35% 1.15% 3.65% 4.95% 6.12% 9.44% 12.14% ROE 16.79% 24.37% 24.64% 21.48% 3.47% 9.92% 10.91% 10.84% 18.75% 34.68% ROCE 22.58% 31.24% 29.57% 22.72% 10.22% 11.50% 11.38% 12.37% 18.33% 28.01% Fixed Asset Turnover 1.32 1.43 1.25 1.13 0.67 0.80 0.91 1.05 1.15 1.22 Receivable days 33.42 25.60 33.69 46.02 32.29 30.99 39.46 48.22 46.72 36.80 Inventory Days 7.29 6.78 7.47 9.40 9.44 8.49 10.10 11.07 11.65 11.22 Payable days 117.83 121.10 148.00 67.98 87.36 66.95 114.25 142.15 57.92 48.59 Cash Conversion Cycle -77.11 -88.72 -106.84 -12.57 -45.63 -27.47 -64.69 -82.86 0.44 -0.57 Total Debt/Equity 0.00 0.01 0.14 0.29 1.32 1.26 0.98 0.59 0.36 1.33 Interest Cover 71.34 42.63 14.87 7.17 1.51 2.89 5.00 6.68 6.17 7.47

Description Mar 23 Mar 22 Mar 21 Mar 20
Book Value (Rs.) 208.62 173.35 111.32 80.25 ROA 15.23% 20.60% 15.64% 9.97% ROE 23.93% 30.55% 28.12% 20.22% ROCE 27.84% 35.69% 30.82% 21.17% Fixed Asset Turnover 1.24 1.31 1.16 1.07 Receivable days 31.66 26.36 33.22 41.54 Inventory Days 6.58 6.69 7.47 9.30 Payable days 115.35 134.33 161.26 46.79 Cash Conversion Cycle -77.10 -101.27 -120.57 4.06 Total Debt/Equity 0.32 0.12 0.31 0.54 Interest Cover 14.01 21.89 8.47 4.16

Top Investors:

sbi small cap fund

axis mutual fund trustee limited a/c axis mutual fund a/c axis small cap fund

hdfc small cap fund

amansa holdings private limited

emerald investments limited

nomura india investment fund mother fund

hdfc life insurance company limited

sbi life insurance co. ltd

icici prudential long term equity fund tax savings

tata aia life insurance co ltd-whole life mid cap equity fund-ulif 009 04/01/07 wle 110

Annual Reports:

News Update:

Krishna Institute of Medical Sciences executes agreement to invest in M/s Meda Institute of Podiatry
11th Jun 2024, 15:50 PM

The company will hold 51% in the M/s Meda Institute of Podiatry
Read More
Krishna Institute of Medical enters into lease agreement to set up Super Specialty Hospital in Bengaluru
31st May 2024, 09:51 AM

The company has entered into a lease deed for 25 years
Read More
Krishna Institute of Medical Sciences executes agreement to invest in M/s. KIMS Hospital Bengaluru
21st May 2024, 10:02 AM

The proceeds of Preference share capital are intended to be utilized for the repayment of an unsecured loan along with interest advanced by KIMS to its wholly-owned subsidiary (KIMS Bengaluru)
Read More
Krishna Inst.Medi - Quarterly Results
16th May 2024, 17:55 PM

Read More

Krishna Institute of Medical Sciences Ltd

Hospital & Healthcare Services

BSE: 543308 | NSE: KIMS

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update:

Krishna Institute of Medical Sciences Ltd

Hospital & Healthcare Services

BSE: 543308 | NSE: KIMS

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update: